In general, drug-induced hERG inhibition has been associated with QT prolongation and the risk of torsade de pointes [42,43] and INa inhibition with QRS widening, AV blockade, and ventricular tachycardia and fibrillation [38,44,45,46]. The gene discussed is KCNH2; the disease is torsades de pointes.